VCM
PROK icon

Voleon Capital Management’s ProKidney PROK Stock Holding History

Voleon Capital Management’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$966K Buy
473,307
+370,609
+361% +$678K 0.02% 479
2026
Q1 		$184K Buy
+102,698
New +$218K ﹤0.01% 755

Other funds holding PROK

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $542M AUM 206.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Voleon Capital Management's PROK Position: Q2 2026 in Review

Voleon Capital Management increased its ProKidney (PROK) stake by 361% in Q2 2026, buying an estimated $678K and bringing the position to 473,307 shares worth $966K. The position accounts for 0.02% of the portfolio, ranked #479.

Voleon Capital Management first reported a position in PROK in Q1 2026 and has held it in 2 quarters since. 71 funds tracked by Wall St. Rank hold PROK as of Q2 2026.

  • Voleon Capital Management held 473,307 shares of ProKidney worth $966K as of Q2 2026.
  • Voleon Capital Management bought 370,609 ProKidney shares in Q2 2026, an estimated $678K.
  • ProKidney made up 0.02% of Voleon Capital Management's portfolio in Q2 2026, its #479 holding.
  • Voleon Capital Management first reported a position in ProKidney in Q1 2026 and has held it in 2 quarters since.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q2 2026.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.